Special Offering :
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
The Europe Small Animal Imaging (In-vivo) Market is expected to grow at a CAGR of 9.1% during 2016 -2022. Rising R&D investments by pharmaceutical companies is a result of rapidly changing industry landscape, specifically expansion of the biotechnology segment. Innovative product launches would be witnessed due to vertical competition in the industry.
The growing number of pharmaceutical and research organizations for the diagnosis of diseases, the growing purchasing power of the end user in the underdeveloped and developing regions would cumulatively add to the growth of the markets. Development of novel and unique high-resolution small animal in-vivo imaging techniques has offered a distinctive opportunity in clinical trials. New imaging devices with high-resolution imaging methodology would present as a significant market opportunity within the small animal imaging (in-vivo) market.
New technologies and their combination with imaging devices will drive the growth of small animal imaging (In-Vivo) market. The report highlights the adoption of Small Animal Imaging (In-vivo) Market in Europe. Based on the Technology, the Europe Small Animal Imaging (In-vivo) Market is segmented into Micro-MRI, Optical Imaging, Nuclear Imaging and Others (Micro-Ultrasound and micro-CT) segment. Based on the Application, the market is bifurcated into Monitoring treatment, Bio-distribution, Cancer cell detection, Biomarkers, Longitudinal studies and Epigenetics segments.
The countries included in the report are Germany, UK, France, Russia, Spain, Italy and Rest of Europe. Key players profiled in the report includes Thermo Fisher Scientific Inc., Mediso Medical Imaging Systems, Promega Corporation, Miltenyi Biotech GmbH, Bruker Corporation, PerkinElmer Inc., Aspect Imaging Ltd., Siemens AG and Fujifilm Holdings Corporation.